Recent Updates
Recently added Catalysts
AIMD Positive Sentiment Score: 75/100

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

Key Takeaway: Ainos, Inc. announced that Jack Lu, the Director of Corporate Development, will present at the Small-Cap Growth Virtual Investor Conference on February 7, 2024. The presentation will allow real-time interaction with investors, along with opportunities for one-on-one meetings. Ainos is a healthcare company focused on innovative testing and therapeutics, expanding its portfolio including low-dose interferon and COVID-19 point-of-care tests. Archived webcasts will be available for those unable to attend the live event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Ainos, Inc. is actively engaging with investors through a live presentation.
  • The company is expanding its innovative product portfolio in healthcare.
  • There is a focus on developing novel technologies for point-of-care testing.

Full Press Release Details

SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced that Jack Lu, the Company’s Director of Corporate Development, will present live at the Small-Cap Growth Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on February 7, 2024.
DATE: February 7th, 2024
TIME: Wednesday, February 7th, 2024 at 9:30AM ET
Available for 1x1 meetings: February 7, 2024, 10AM-12PM ET
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Headquartered in San Diego, California, Ainos, Inc. is a diversified healthcare company engaged in developing innovative medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. In addition to its proprietary therapeutics using low-dose non-injectable interferon, Ainos has also expanded its product portfolio to include Volatile Organic Compounds (VOC) and COVID-19 POCTs. Powered by its AI Nose platform, the lead POCT candidate, Ainos Flora, is a telehealth-friendly POCT for women's health and certain common STIs. To learn more, visit https://www.ainos.com.
Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Tel: +1 646-224-6971
Virtual Investor Conferences
SVP Corporate Services, Investor Access

Frequently Asked Questions

When is Ainos, Inc. presenting at the investor conference?

Ainos, Inc. will present on February 7, 2024, at 9:30 AM ET.

How can I attend the Ainos investor conference presentation?

You can attend by visiting https://bit.ly/496OeL9 and pre-registering.

Will the event be available after it ends?

Yes, an archived webcast will be available after the event.

What technologies is Ainos, Inc. focused on developing?

Ainos is focused on point-of-care testing and low-dose interferon therapeutics.

How can I follow Ainos, Inc. for updates?

Follow Ainos on X and LinkedIn for the latest updates.

Last updated: Feb 1, 2024